NO20051471L - Piperidin-2,6-dionpamoatsalter og deres anvendelse for behandling av stressrelaterte affektforstyrrelser - Google Patents
Piperidin-2,6-dionpamoatsalter og deres anvendelse for behandling av stressrelaterte affektforstyrrelserInfo
- Publication number
- NO20051471L NO20051471L NO20051471A NO20051471A NO20051471L NO 20051471 L NO20051471 L NO 20051471L NO 20051471 A NO20051471 A NO 20051471A NO 20051471 A NO20051471 A NO 20051471A NO 20051471 L NO20051471 L NO 20051471L
- Authority
- NO
- Norway
- Prior art keywords
- dione
- stress
- treatment
- dimethylpiperidine
- pamoate
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 title abstract 3
- 208000019022 Mood disease Diseases 0.000 title abstract 2
- KNCYXPMJDCCGSJ-UHFFFAOYSA-N piperidine-2,6-dione Chemical compound O=C1CCCC(=O)N1 KNCYXPMJDCCGSJ-UHFFFAOYSA-N 0.000 title 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 2
- 208000019695 Migraine disease Diseases 0.000 abstract 2
- 241000700159 Rattus Species 0.000 abstract 2
- 230000036506 anxiety Effects 0.000 abstract 2
- 150000003840 hydrochlorides Chemical class 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 201000002859 sleep apnea Diseases 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 230000004580 weight loss Effects 0.000 abstract 2
- YOGIZNRHMDDKAA-UHFFFAOYSA-N 3-(3,5-dimethoxyphenyl)-3-[3-(dimethylamino)propyl]-4,4-dimethylpiperidine-2,6-dione Chemical compound COC1=CC(OC)=CC(C2(CCCN(C)C)C(CC(=O)NC2=O)(C)C)=C1 YOGIZNRHMDDKAA-UHFFFAOYSA-N 0.000 abstract 1
- UJFNSGBGJMRZKS-UHFFFAOYSA-N agn-2979 Chemical compound COC1=CC=CC(C2(CCCN(C)C)C(CC(=O)NC2=O)(C)C)=C1 UJFNSGBGJMRZKS-UHFFFAOYSA-N 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0219639.2A GB0219639D0 (en) | 2002-08-22 | 2002-08-22 | Novel piperidin-2,6-dione salts and their use for the treatment of stress-related affective disorders |
| PCT/IB2003/003698 WO2004017970A1 (en) | 2002-08-22 | 2003-08-18 | Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051471L true NO20051471L (no) | 2005-05-23 |
Family
ID=9942831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051471A NO20051471L (no) | 2002-08-22 | 2005-03-21 | Piperidin-2,6-dionpamoatsalter og deres anvendelse for behandling av stressrelaterte affektforstyrrelser |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7514454B2 (uk) |
| EP (1) | EP1539160B1 (uk) |
| JP (1) | JP2005538146A (uk) |
| KR (1) | KR20050038014A (uk) |
| CN (1) | CN1678316A (uk) |
| AT (1) | ATE330605T1 (uk) |
| BR (1) | BR0313674A (uk) |
| CA (1) | CA2495377A1 (uk) |
| CY (1) | CY1105541T1 (uk) |
| DE (1) | DE60306396T2 (uk) |
| DK (1) | DK1539160T3 (uk) |
| EA (1) | EA007900B1 (uk) |
| ES (1) | ES2268474T3 (uk) |
| GB (1) | GB0219639D0 (uk) |
| GE (1) | GEP20074051B (uk) |
| IL (1) | IL166941A (uk) |
| MX (1) | MXPA05001919A (uk) |
| NO (1) | NO20051471L (uk) |
| NZ (1) | NZ538341A (uk) |
| PL (1) | PL373416A1 (uk) |
| PT (1) | PT1539160E (uk) |
| UA (1) | UA80144C2 (uk) |
| WO (1) | WO2004017970A1 (uk) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6987111B2 (en) * | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
| GB0518763D0 (en) * | 2005-09-14 | 2005-10-19 | Prestwick Pharmaceuticals Inc | Treatment of hypertension |
| US20090018182A1 (en) * | 2006-06-28 | 2009-01-15 | Sigalit Levi | Crystalline forms of atorvastatin |
| EP2833866B2 (en) | 2012-04-04 | 2024-11-27 | Intervet International B.V. | Soft chewable pharmaceutical products |
| CN105727117A (zh) * | 2016-02-03 | 2016-07-06 | 瓮杰林 | 一种治疗前列腺增生的药物及其制备方法 |
| CN106831594B (zh) * | 2017-01-18 | 2018-02-02 | 力赛生物医药科技(厦门)有限公司 | 可乐定双羟萘酸盐及其制备方法 |
| CN115702894A (zh) * | 2021-08-11 | 2023-02-17 | 朱信红 | 一种用于止吐的缓释组合物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1455687A (en) * | 1972-12-28 | 1976-11-17 | Aspro Nicholas Ltd | Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines |
| US4461771A (en) * | 1983-03-01 | 1984-07-24 | Gittos Maurice W | Treatment of migraine with dioxopiperidine derivatives |
| DE3686622T2 (de) * | 1985-09-11 | 1993-04-01 | British Tech Group | Verwendung von dioxopiperidin-derivaten zur behandlung von anxietas, zur herabsetzung von chronischen abnormal hohen gehirn-spiegeln serotonins oder 5-hydroxy-indolessigsaeure und zur behandlung von bakteriellen oder viralen infektionen. |
| DE3779991T2 (de) | 1986-09-08 | 1993-02-04 | British Tech Group | Dioxopiperidin-derivate enthaltende anxiolytische zusammensetzungen. |
| GB8716338D0 (en) | 1987-07-10 | 1987-08-19 | Nat Res Dev | Anti-anxiogenic compositions |
| GB2379216A (en) * | 2001-08-28 | 2003-03-05 | Maurice Ward Gittos | Piperidin-2,6-dione salts useful for the treatment of stress-related affective disorders |
-
2002
- 2002-08-22 GB GBGB0219639.2A patent/GB0219639D0/en not_active Ceased
-
2003
- 2003-08-18 EA EA200500242A patent/EA007900B1/ru not_active IP Right Cessation
- 2003-08-18 NZ NZ538341A patent/NZ538341A/en not_active IP Right Cessation
- 2003-08-18 ES ES03792588T patent/ES2268474T3/es not_active Expired - Lifetime
- 2003-08-18 MX MXPA05001919A patent/MXPA05001919A/es active IP Right Grant
- 2003-08-18 JP JP2004530467A patent/JP2005538146A/ja active Pending
- 2003-08-18 WO PCT/IB2003/003698 patent/WO2004017970A1/en not_active Ceased
- 2003-08-18 US US10/524,693 patent/US7514454B2/en not_active Expired - Fee Related
- 2003-08-18 CN CNA038199149A patent/CN1678316A/zh active Pending
- 2003-08-18 PL PL03373416A patent/PL373416A1/xx not_active Application Discontinuation
- 2003-08-18 CA CA002495377A patent/CA2495377A1/en not_active Abandoned
- 2003-08-18 UA UAA200501443A patent/UA80144C2/uk unknown
- 2003-08-18 AT AT03792588T patent/ATE330605T1/de active
- 2003-08-18 PT PT03792588T patent/PT1539160E/pt unknown
- 2003-08-18 DK DK03792588T patent/DK1539160T3/da active
- 2003-08-18 DE DE60306396T patent/DE60306396T2/de not_active Expired - Lifetime
- 2003-08-18 KR KR1020057002687A patent/KR20050038014A/ko not_active Ceased
- 2003-08-18 EP EP03792588A patent/EP1539160B1/en not_active Expired - Lifetime
- 2003-08-18 GE GEAP8650A patent/GEP20074051B/en unknown
- 2003-08-18 BR BR0313674-4A patent/BR0313674A/pt not_active Application Discontinuation
-
2005
- 2005-02-16 IL IL166941A patent/IL166941A/en not_active IP Right Cessation
- 2005-03-21 NO NO20051471A patent/NO20051471L/no not_active Application Discontinuation
-
2006
- 2006-09-15 CY CY20061101323T patent/CY1105541T1/el unknown
-
2009
- 2009-03-18 US US12/382,511 patent/US20090182012A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005538146A (ja) | 2005-12-15 |
| NZ538341A (en) | 2006-09-29 |
| CN1678316A (zh) | 2005-10-05 |
| KR20050038014A (ko) | 2005-04-25 |
| EA007900B1 (ru) | 2007-02-27 |
| DE60306396D1 (de) | 2006-08-03 |
| AU2003255947A1 (en) | 2004-03-11 |
| US20060025443A1 (en) | 2006-02-02 |
| PT1539160E (pt) | 2006-10-31 |
| GB0219639D0 (en) | 2002-10-02 |
| ATE330605T1 (de) | 2006-07-15 |
| UA80144C2 (uk) | 2007-08-27 |
| PL373416A1 (en) | 2005-08-22 |
| BR0313674A (pt) | 2005-06-21 |
| CY1105541T1 (el) | 2010-07-28 |
| ES2268474T3 (es) | 2007-03-16 |
| MXPA05001919A (es) | 2005-06-03 |
| DE60306396T2 (de) | 2007-05-03 |
| IL166941A (en) | 2010-04-15 |
| WO2004017970A1 (en) | 2004-03-04 |
| EP1539160B1 (en) | 2006-06-21 |
| EA200500242A1 (ru) | 2005-08-25 |
| GEP20074051B (en) | 2007-02-26 |
| CA2495377A1 (en) | 2004-03-04 |
| US7514454B2 (en) | 2009-04-07 |
| EP1539160A1 (en) | 2005-06-15 |
| US20090182012A1 (en) | 2009-07-16 |
| DK1539160T3 (da) | 2006-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062136L (no) | Imidazopyrazintyrosin-kinaseinhibitorer | |
| NO20063928L (no) | Substituerte kinolinforbindelser | |
| NO341591B1 (no) | 3-Z-[1-(4-(N-((4-metyl-piperazin-1-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-1-fenyl-metylen]-6-metoksykarbonyl-2-indolinon, tautomerene, diastereomerene, enantiomerene, blandinger derav og saltene derav, og i kombinasjon med en ytterligere farmakologisk aktiv substans, for anvendelse i forebygging eller behandling av fibrose ved revmatoid artritt | |
| NO20084845L (no) | 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig | |
| NO20070588L (no) | Piperidinderivater som NK1-antagonister. | |
| NO20083411L (no) | Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling | |
| NO20084872L (no) | 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig | |
| NO20021781L (no) | Heteroalkylamino-substituerte bicykliske nitrogenheterocykler som inhibitorer for P38-proteinkinase | |
| NO20071193L (no) | Fluorsubstituerte sykloalkanoindoler og deres anvendelse som prostaglandin D2-reseptorantagonister | |
| BRPI0508461B1 (pt) | Diaminopirimidinas, seus usos, e composição farmacêutica | |
| NO20032861L (no) | Heteroarylurea nevropeptid Y Y5-reseptorantagonister | |
| NO990551L (no) | Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister | |
| DE60315674D1 (de) | Neue imidazopyridine und ihre verwendung | |
| NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| NO20042141L (no) | Terapeutiske quinolonforbindelser med 5-HT-antagonistiske egenskaper | |
| WO2003004480A3 (en) | Substituted piperazine and diazepanes as histamine h3 receptor agonists | |
| DE60305514D1 (de) | Neue verwendung von benzothiazolderivaten | |
| NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
| BR0206513A (pt) | Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos | |
| NO20051471L (no) | Piperidin-2,6-dionpamoatsalter og deres anvendelse for behandling av stressrelaterte affektforstyrrelser | |
| ATE297929T1 (de) | Azabicycloalkan-derivate zur verwendung als inhibitoren der serotonin-wiederaufnahme und als 5ht2a antagonisten | |
| NO20060020L (no) | 3-fluorpiperidiner som NMDA/NR2B-antagonister | |
| NO20065327L (no) | Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid. | |
| NO20075209L (no) | Substituerte aryl 1,4-pyrazinderivater | |
| NO20051967L (no) | 3,4-disubstituerte pyroler og deres anvendelse ved behandling av inflammatoriske sykdommer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |